Skip to main content

Table 4 The change in mean (SD) for BCVA, PED height and PED width 1 year after switch to Aflibercept in different PED morphologies and retinal fluid

From: Clinical response of pigment epithelial detachment associated with neovascular age-related macular degeneration in switching treatment from Ranibizumab to Aflibercept

PED Morphology

Number

BCVA Change (ETDRS letters)

PED height change (micrometers)

PED width change (micrometers)

Hollow

17

3.41 (13.20)

−34.0 (71.1)

−43.6 (414.3)

Mixed

18

0.00 (7.78)

− 91.1 (152.1)

− 0.111 (647.7)

Solid

15

1.93 (6.89)

−20.9 (136.4)

26.6 (385.2)

Retinal Fluid

 None

1

−2.00

6.0

48.0

 SRF

32

2.53 (7.28)

− 69.5 (131.5)

93.9 (474.9)

 IRF

9

1.78 (7.10)

−2.78 (118.0)

−97.4 (571.8)

 SRF and IRF

8

−1.00 (18.67)

−36.3 (118.5)

− 314.9 (419.1)